Probiodrug AG PBD Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

10:43 EST 15 Nov 2017 | BioPortfolio Report Blog


Probiodrug AG Probiodrug is a biopharmaceutical company that conducts research and development of therapies for Alzheimer's disease. The company provides three pipeline drug candidates such as PQ912, PBDC06 and PQ1565. Its PQ912 drug candidate is a small molecule glutaminyl cyclase QC inhibitor in Phase II clinical trials that inhibits QCenzyme for animal models. Probiodrug's PBDC06 is a monoclonal antibody under evaluation, which clear toxic pyroglutamateAbeta pGluAbeta in the brain. The company's PQ1565 is a second QC inhibitor in preclinical stage and demonstrated attractive druglike properties. It developes a therapeutic approach, dipeptidyl peptidase 4 DP4 inhibitors for the treatment of diabetes. Probiodrug is headquartered in Halle, Germany.

Probiodrug AG Key Recent Developments

Aug 31,2017: Probiodrug reports financial results for H1 2017 and corporate update

May 12,2017: Probiodrug reports First Quarter 2017 Business Update

Mar 30,2017: Probiodrug reports full year 2016 financial results

Mar 28,2017: Probiodrug to present at Alzheimer's and Parkinson's Diseases Congress

Nov 10,2016: Probiodrug Reports Third Quarter 2016 Business Update

This comprehensive SWOT profile of Probiodrug AG provides you an indepth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Probiodrug AG including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. excluding weekends.

The profile contains critical company information including*,

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Original Article: Probiodrug AG PBD Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300


More From BioPortfolio on "Probiodrug AG PBD Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300"

Quick Search


Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...